… Silent corticotroph adenoma (SCA) is defined as a pituitary tumour with evidence of
immunoreactive adrenocortitroph hormone (ACTH) in tumour cells in the absence of clinical …

… Silent corticotroph adenomas (SCAs) are defined as clinically nonfunctioning pituitary
adenomas (NFPAs) with positive immunoreactivity for adrenocorticotropic hormone (ACTH). …

… Silent corticotroph adenomas (SCAs) were first described in 1978 as clinically
nonfunctioning pituitary adenomas (NFPAs) staining positive for corticotropin (ACTH) by …

… Silent corticotroph pituitary adenomas (SCA) are defined as pituitary adenomas showing …
They account for 1.1-6% of surgically removed pituitary adenomas. Currently, two distinct …

… In some pituitary tumor subtypes such as in corticotroph tumors, complications of hormonal
… hypersecretion in invasive/recurrent corticotroph pituitary tumors is of paramount importance. …

… prospectively maintained database of all pituitary tumors treated at our institution between …
examination on all clinically non-functioning pituitary adenomas for ACTH was not carried out, …

… Our findings suggest that SCAs are relatively aggressive pituitary adenomas with a higher
propensity for tumor progression. These data corroborate findings from prior studies, lending …

… tumour stabilisation in a patient with a silent corticotroph PC … cases (one corticotroph, one
immunonegative tumour) were … another corticotroph tumour continued to demonstrate tumour …

… The 2017 World Health Organization (WHO) classification of pituitary adenomas defines
corticotroph adenomas as those that arise from adenohypophyseal cells of TPIT lineage and …

… Silent corticotroph cell pituitary adenomas are tumors that, by … Unlike many types of
pituitary adenomas in which the … In addition, we report double pituitary adenomas in 1 patient …